Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma

doi:10.3748/wjg.v28.i2.176

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7755)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

443

WORD

198

HTML

4445

Figures (1-3)

348

Tables (1-2)

416

Sum=5850

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

272

Download

445

Sum=717

Publishing Process of This Article

Item

Count

Browse

397

Download

791

Sum=1188

Jan 14, 2022 (publication date) through Nov 29, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jan 14, 2022; 28(2): 176-187
Published online Jan 14, 2022. doi: 10.3748/wjg.v28.i2.176

Full Size Figure Download Figure

Figure 3 Multimodality of the nanotheranostic platform. HCC: Hepatocellular carcinoma.

Citation: Ladju RB, Ulhaq ZS, Soraya GV. Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma. World J Gastroenterol 2022; 28(2): 176-187
URL: https://www.wjgnet.com/1007-9327/full/v28/i2/176.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i2.176